Arabic Arabic English English French French German German
dark

Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent Developments

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Idera Pharmaceuticals Announces Corporate Updates

Next Post

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Related Posts
Total
0
Share